Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?

New parliamentary term will be packed with legislation for life sciences and healthcare businesses

This decision shows the court assessing patentability in a real-world practical context, recognising the uncertainties of R&D that only later

With technological advances increasing access to patient support programmes, what legal and regulatory issues do pharmaceutical companies need to take

Successor to a coronavirus support scheme as well as a new sovereign investment partnership offer crucial access to capital for

Substantial change is now set for the UK M&A landscape, with a wide range of transactions in scope, including current

Pressure for an IP rights waiver to fight the pandemic threatens vaccine companies' ability to develop and protect their trade

What role can biofuels play in fighting climate change and can CRISPR sequencing technology help it reach its potential?

The pandemic, coupled with the significant economic downturn, continues to produce pressures on businesses that could prove to be fertile

Attracting, and retaining, talent in today's competitive job market is a key contributor to the success of many businesses. This

Private, flexible and easily enforceable across much of the world, it is not hard to see why international arbitration is

With the ability to provide a secure and reliable record of vaccine delivery, the technology is set to play a